Hypertension and ischemic heart disease

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F12%3A%230001685" target="_blank" >RIV/65269705:_____/12:#0001685 - isvavai.cz</a>

Výsledek na webu

<a href="http://www.sciencedirect.com/science/article/pii/S0010865012001191?=s5" target="_blank" >http://www.sciencedirect.com/science/article/pii/S0010865012001191?=s5</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.crvasa.2012.11.002" target="_blank" >10.1016/j.crvasa.2012.11.002</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Hypertension and ischemic heart disease

Popis výsledku v původním jazyce

ypertension is one of the major risk factors for ischemic heart disease and appropriate control of blood pressure is the cornerstone of both primary and secondary ischemic heart disease prevention. Effective blood pressure (BP) control is recommended inprimary prevention, i.e., maintaining blood pressure <140/90 mmHg, while in secondary prevention values <130/85 mmHg used to be recommended. Treatment of hypertension in patients with ischemic heart disease is based on ACE inhibitors and/or AII antagonists (trials HOPE, EUROPA, and PEACE) in combination with beta blockers or with verapamil if beta blockers are not tolerated.According to epidemiologic data, cardiovascular mortality increases with blood pressure, starting as low as from the 110/70 mmHg level. Czech, European, and American guidelines from the early 21st century recommend that blood pressure in patients with ischemic heart disease (IHD) be maintained below 130/80 mmHg. Data from the INVEST a ACCORD trials led, however, to r

Název v anglickém jazyce

Hypertension and ischemic heart disease

Popis výsledku anglicky

ypertension is one of the major risk factors for ischemic heart disease and appropriate control of blood pressure is the cornerstone of both primary and secondary ischemic heart disease prevention. Effective blood pressure (BP) control is recommended inprimary prevention, i.e., maintaining blood pressure <140/90 mmHg, while in secondary prevention values <130/85 mmHg used to be recommended. Treatment of hypertension in patients with ischemic heart disease is based on ACE inhibitors and/or AII antagonists (trials HOPE, EUROPA, and PEACE) in combination with beta blockers or with verapamil if beta blockers are not tolerated.According to epidemiologic data, cardiovascular mortality increases with blood pressure, starting as low as from the 110/70 mmHg level. Czech, European, and American guidelines from the early 21st century recommend that blood pressure in patients with ischemic heart disease (IHD) be maintained below 130/80 mmHg. Data from the INVEST a ACCORD trials led, however, to r

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Cor et Vasa

ISSN

0010-8650

e-ISSN

—

Svazek periodika

54

Číslo periodika v rámci svazku

11-12

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

5

Strana od-do

"e433"-"e438"

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—